SPOTLIGHT -
The Approval of Fenfluramine for Treating Dravet Syndrome
Two experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.
Cannabidiol’s Approval on Dravet and Lennox-Gastaut Syndromes Continued
Drs Thiele and Wirrell continue analyzing the benefits of cannabidiol as a therapeutic option for patients with Dravet or Lennox-Gastaut syndromes.
Elaine Wirrell, MD: Adjusting Epilepsy Care For Telemedicine
The director of pediatric epilepsy and professor of neurology at Mayo Clinic details the rampant acceleration of telemedicine and how her practice is adjusting to the COVID-19 pandemic.
